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Dear Editor,
A 61-year-old woman (patient A) was
admitted to our intensive care unit
with carbamazepine overdose. Car-
bamazepine total plasma
concentration determined by enzyme-
multiplied immunoassay technique
(EMIT) was 52.5 mg/L (reference
4–12 mg/L) of which 22.7 mg/L was
unbound (43%). Unbound carbamaz-
epine was determined in plasma by
EMIT after ultraﬁltration (Amicon
Ultra centrifugal ﬁlter (Millipore),
2,500 rpm, 30 min at 25C). Despite
supportive care (pacemaker, inotropes
and vasopressors) and multiple acti-
vated charcoal administration, the
patient died shortly after admission as
a result of refractory shock.
Soon after, a 41-year-old man
(patient B) was admitted after resus-
citation due to ventricular ﬁbrillation.
For epilepsy he was treated with
carbamazepine (400 mg 5 times/day).
As a result of repeated ventricular
ﬁbrillation, intravenous amiodarone
(300 mg/day) was started. Two days
later a deep coma developed. Because
of a high daily dose of carbamazepine
and its interaction with amiodarone,
we suspected a carbamazepine intox-
ication. Total carbamazepine plasma
concentration was 27.4 mg/L of
which 10.9 mg/L was unbound
(40%). Carbamazepine intoxication
was treated with multiple-dose acti-
vated charcoal and high-ﬂux
haemodialysis (HF-HD); ﬁlter Frese-
nius Helixon
 FX1000, blood ﬂow
350 mL/min, dialysate ﬂow
500 mL/min, ultraﬁltration rate
120 mL/h, ultraﬁltration coefﬁcient
75 mL/(h mmHg). Carbamazepine
plasma concentration decreased to
13.0 mg/L (4.1 mg/L unbound; 32%)
(Fig. 1). The patient fully recovered.
Treatment of carbamazepine
intoxication consists of supportive
care, prevention of further absorption
and enhancement of elimination via
haemoperfusion [1, 2]. But haemop-
erfusion has serious adverse effects
and the facilities are often not avail-
able [1, 3]. Effectiveness of
haemodialysis depends on drug char-
acteristics, dialysis system properties
and dialysis conditions. Haemodialy-
sis in carbamazepine overdose is
considered not to be efﬁcacious
because of low hydrophilicity
(Log P = 1.98) and the high degree
of protein binding (70–80%),
although carbamazepine is small
enough for ﬁltration (236 Da) and
has a low distribution volume
(0.8–1.8 L/kg) [1].
Elimination rate constants (k),
calculated as k = ln 2/half-life (h),
reﬂect the effectiveness of the elimi-
nation route. Overall k is deﬁned as
the sum of all individual k values.
Calculated individual k values in
patient B were 0.009/h for endoge-
nous metabolism, 0.059/h for dialysis
(including membrane adsorption) and
0.039/h for charcoal treatment.
Endogenous k was calculated from
the time period in which no activated
charcoal or HF-HD was applied. k of
activated charcoal was calculated by
subtracting k endogenous from
k overall when only endogenous
clearance and activated charcoal
Fig. 1 Carbamazepine total (solid circles) and unbound (open circles) plasma concentra-
tions in patient B. Therapeutic range for total plasma concentrations 4–12 mg/L
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k overall during HF-HD minus
k endogenous and k activated char-
coal. Limited blood sampling during
the initial rapid clearance of free drug
from the plasma by HF-HD may
partly hamper the interpretation of the
results. However, on the basis of the
half-life initially and later on during
HF-HD, we assume that no signiﬁcant
rapid initial phase took place
(see Fig. 1).
HF-HD was more effective than
multiple activated charcoal treatment
alone, whereas the combination of
both was about ten times more
effective than endogenous clearance.
Probably, endogenous k was
decreased because of the presence of
amiodarone, a CYP3A4 inhibitor [4].
Owing to the increased unbound drug
concentration in carbamazepine
intoxication, HF-HD proved to be an
effective extracorporeal elimination
technique.
In conclusion, HF-HD is an effec-
tive extracorporeal elimination
technique in carbamazepine intoxi-
cation as a result of the increased
unbound drug fraction and can
replace haemoperfusion.
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